Aranesp is the trade name for Darbepoetin alfa, a synthetic version of erythropoietin, which stimulates the production of red blood cells. Aranesp has been used since its approval by the U.S. Food and Drug Administration (FDA) in 2001 to treat patients with anemia, as well as chronic renal failure. It has been frequently prescribed to individuals suffering anemia as a byproduct of chemotherapy.
The FDA has required black box warnings on all sales of Darbepoetin alfa in the United States, citing a number of potential adverse health risks, including:
If you experienced side effects after being prescribed Aranesp, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
Federal and State Legislation Intended to Maximize the Safety of Minors on the Internet The digital age has brought unt... Read More
Its Benefits and Why Some Corporations Try to Prevent It In our work, most of us look for something that rewards our ef... Read More
The Legal Process for Limiting or Preventing Access to Your Juvenile Records It’s well-documented that our brains do ... Read More
How It Works